Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Today 12:54 EST
From CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
October 31, 2024
From CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
October 30, 2024
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
October 24, 2024
From CNBC.com News
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
October 23, 2024
From Benzinga
From CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
October 23, 2024
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
October 15, 2024
From CNBC.com News
Cramer's Lightning Round: Uranium Energy is 'the real deal'
October 14, 2024
From CNBC.com News
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
October 11, 2024
From CNBC.com News
Ozempic underworld: Inside the black market of obesity drugs
October 09, 2024
From CNBC.com News
CNBC Daily Open: October’s gravity bringing stocks down
October 04, 2024
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
October 03, 2024
From CNBC.com News
Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
October 01, 2024
From CNBC.com News
East and Gulf Coast ports strike, with ILA longshoremen walking off job, stranding billions in trade
October 01, 2024
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
September 25, 2024
From CNBC.com News
5 things to know before the stock market opens Wednesday
September 25, 2024
From CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
September 24, 2024
From CNBC.com News
From CNBC.com News
Tuesday's big stock stories: What's likely to move the market in the next trading session
September 23, 2024
From CNBC.com News
Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100
September 22, 2024
From Benzinga
FTC sues drug middlemen for allegedly inflating insulin prices
September 20, 2024
From CNBC.com News
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
September 18, 2024
From CNBC.com News
From CNBC.com News
How the Research Triangle has helped make North Carolina one of America's fastest-growing economies
September 16, 2024
From CNBC.com News
CNBC Daily Open: All key data is in — and it's made the Fed's policy path more uncertain
September 12, 2024
Tickers
JOBS
From CNBC.com News
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
September 12, 2024
From CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
September 10, 2024
From CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
September 05, 2024
From CNBC.com News
5 things to know before the stock market opens Tuesday
September 03, 2024
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.